The first phase of construction started in the second quarter of 2011. The construction will be fully completed by mid-2012. Full drug production is expected to start by mid-2013.
-
Massachusetts-based radiopharmaceutical product supplier, Pharmalucence, is... -
The facility is intended to modernise production assets for use in the... -
It will also serve as the company headquarters. Investment on the facility is... -
The first phase of construction started in the second quarter of 2011. The... -
It will feature state-of-the-art automation and employ barrier isolation and... -
The facility will provide manufacturing for the entire Pharmalucence product...
Twitter
Facebook